Vitiligo affects around 1% of the population, all races and skin types, but may appear more noticeable in people with darker skin tones. Vitiligo is characterised by white patches appearing on the skin, known as depigmentation. At The Skin Hospital we understand the significant psychological impact vitiligo can have on a person’s quality of life.
Trial for Adults with Vitiligo:
Participants: Aged 18 – 65 years old with active non-segmental vitiligo
Drug Type and Administration: PF-06651600 or PF-06700841 or placebo (by oral tablets)
Add-on therapy: Narrow-band UVB phototherapy
Status and Location: Upcoming at Darlinghurst
Additional information at ClinicalTrials.gov
Fill in your details in the form below to register your interest. Our clinical trials coordinator will be in touch shortly to discuss your eligibility for the trial.
Upon receiving your consent, we can add your name and contact details to our database and contact you for upcoming trials.
Alternatively, ring us on 02 8279 2739 to speak to our clinical trials team today or Email email@example.com